On ECHEMI
Home > Drugs > Sinopharm A-Think Pharmaceutical Co., Ltd.
Sinopharm A-Think Pharmaceutical Co., Ltd.
  • Founded in:

    1997-12-10
  • Country:

    China China
  • Address:

    No. 111, Yixin Road, Shuangyang Economic Development Zone, Changchun
  • Tax NO.:

    912201012440638092
  • Registered Funds:

    100 million yuan
  • Website:

  • Email:

Related Drugs
Octreotide Acetate Injection
The main ingredient of this product is octreotide acetate. Chemical name: D-phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophanyl-L-lysyl-L-threonyl-L-cysteinyl-L-threonyl cyclo (2,7) disulfide acetate. Chemical structure: Molecular formula: C49H66N10010S2·xC2H4O2 Molecular weight: 1019.26·x60.02 Excipients: lactic acid, mannitol.
Name Description Content CAS NO. Registered Holders
Octreotide acetate

It can inhibit the pathological excessive secretion of growth hormone, thyroid-stimulating hormone, gastrointestinal and pancreatic endocrine hormones; it can selectively reduce the blood flow and pressure of the portal vein and its collateral circulation, and reduce the pressure of varicose veins in the esophagus and gastric fundus; it can inhibit gallbladder emptying and have a therapeutic effect on pancreatic lesions; it can inhibit the secretion of gastric acid and gastrin, and improve the blood supply to the gastric mucosa; it can inhibit gastrointestinal motility.

More

It can inhibit the pathological excessive secretion of growth hormone, thyroid-stimulating hormone, gastrointestinal and pancreatic endocrine hormones; it can selectively reduce the blood flow and pressure of the portal vein and its collateral circulation, and reduce the pressure of varicose veins in the esophagus and gastric fundus; it can inhibit gallbladder emptying and have a therapeutic effect on pancreatic lesions; it can inhibit the secretion of gastric acid and gastrin, and improve the blood supply to the gastric mucosa; it can inhibit gastrointestinal motility.

83150-76-9 44
Octreotide Acetate Injection
Name Description Content CAS NO. Registered Holders
Octreotide acetate

It can inhibit the pathological excessive secretion of growth hormone, thyroid-stimulating hormone, gastrointestinal and pancreatic endocrine hormones; it can selectively reduce the blood flow and pressure of the portal vein and its collateral circulation, and reduce the pressure of varicose veins in the esophagus and gastric fundus; it can inhibit gallbladder emptying and have a therapeutic effect on pancreatic lesions; it can inhibit the secretion of gastric acid and gastrin, and improve the blood supply to the gastric mucosa; it can inhibit gastrointestinal motility.

More

It can inhibit the pathological excessive secretion of growth hormone, thyroid-stimulating hormone, gastrointestinal and pancreatic endocrine hormones; it can selectively reduce the blood flow and pressure of the portal vein and its collateral circulation, and reduce the pressure of varicose veins in the esophagus and gastric fundus; it can inhibit gallbladder emptying and have a therapeutic effect on pancreatic lesions; it can inhibit the secretion of gastric acid and gastrin, and improve the blood supply to the gastric mucosa; it can inhibit gastrointestinal motility.

83150-76-9 44
Ginseng stem and leaf total saponin tablets
The main ingredients include ginsenosides Rg1, Re, Rc, Rb2, Rd, etc.
Name Description Content CAS NO. Registered Holders
Ginsenoside Rg1

Enhance the body's stress resistance, adjust endocrine or autonomic nervous system disorders, resist fatigue, and enhance myocardial contractility and increase cardiac output

More

Enhance the body's stress resistance, adjust endocrine or autonomic nervous system disorders, resist fatigue, and enhance myocardial contractility and increase cardiac output

22427-39-0 0
Re-ChIP-IT

Enhance the body's stress resistance, adjust endocrine or autonomic nervous system disorders, resist fatigue, and enhance myocardial contractility and increase cardiac output

More

Enhance the body's stress resistance, adjust endocrine or autonomic nervous system disorders, resist fatigue, and enhance myocardial contractility and increase cardiac output

0
Rc

Enhance the body's stress resistance, adjust endocrine or autonomic nervous system disorders, resist fatigue, and enhance myocardial contractility and increase cardiac output

More

Enhance the body's stress resistance, adjust endocrine or autonomic nervous system disorders, resist fatigue, and enhance myocardial contractility and increase cardiac output

0
Rb2

Enhance the body's stress resistance, adjust endocrine or autonomic nervous system disorders, resist fatigue, and enhance myocardial contractility and increase cardiac output

More

Enhance the body's stress resistance, adjust endocrine or autonomic nervous system disorders, resist fatigue, and enhance myocardial contractility and increase cardiac output

0
Rd

Enhance the body's stress resistance, adjust endocrine or autonomic nervous system disorders, resist fatigue, and enhance myocardial contractility and increase cardiac output

More

Enhance the body's stress resistance, adjust endocrine or autonomic nervous system disorders, resist fatigue, and enhance myocardial contractility and increase cardiac output

0
Octreotide Acetate Injection
The main ingredient of this product is octreotide acetate. Chemical name: D-phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophanyl-L-lysyl-L-threonyl-L-cysteinyl-L-threonyl cyclo (2,7) disulfide acetate. Chemical structure: Molecular formula: C49H66N10010S2·xC2H4O2 Molecular weight: 1019.26·x60.02 Excipients: lactic acid, mannitol.
Name Description Content CAS NO. Registered Holders
Octreotide acetate

It can inhibit the pathological excessive secretion of growth hormone, thyroid-stimulating hormone, gastrointestinal and pancreatic endocrine hormones; it can selectively reduce the blood flow and pressure of the portal vein and its collateral circulation, and reduce the pressure of varicose veins in the esophagus and gastric fundus; it can inhibit gallbladder emptying and have a therapeutic effect on pancreatic lesions; it can inhibit the secretion of gastric acid and gastrin, and improve the blood supply to the gastric mucosa; it can inhibit gastrointestinal motility.

More

It can inhibit the pathological excessive secretion of growth hormone, thyroid-stimulating hormone, gastrointestinal and pancreatic endocrine hormones; it can selectively reduce the blood flow and pressure of the portal vein and its collateral circulation, and reduce the pressure of varicose veins in the esophagus and gastric fundus; it can inhibit gallbladder emptying and have a therapeutic effect on pancreatic lesions; it can inhibit the secretion of gastric acid and gastrin, and improve the blood supply to the gastric mucosa; it can inhibit gastrointestinal motility.

83150-76-9 44
Sodium norcantharidate for injection
Main ingredients: The main active ingredient is sodium norcantharidin.
Name Description Content CAS NO. Registered Holders
SodiuM DeMethylcantharidate

In vitro tests of this product have a destructive or inhibitory effect on the morphology or proliferation of cell lines such as liver cancer, esophageal cancer, laryngeal cancer, lung cancer, and cervical cancer. In vivo tests have a certain inhibitory effect on mouse Ehrlich ascites carcinoma, sarcoma-180 and solid liver cancer. It can increase the respiratory control rate and lysosomal enzyme activity of mitochondria in H22 mouse ascites liver cancer cells, interfere with cancer cell division, block in the M phase, and affect its cycle speed. This product can destroy the skeleton of cancer cells (microfilaments, microtubules), affect the ultrastructure of cancer cells, and cause damage to mitochondria, microvilli and plasma membranes. It can inhibit DNA synthesis of cancer cells, but it does not inhibit normal bone marrow cells, and can increase white blood cells.

More

In vitro tests of this product have a destructive or inhibitory effect on the morphology or proliferation of cell lines such as liver cancer, esophageal cancer, laryngeal cancer, lung cancer, and cervical cancer. In vivo tests have a certain inhibitory effect on mouse Ehrlich ascites carcinoma, sarcoma-180 and solid liver cancer. It can increase the respiratory control rate and lysosomal enzyme activity of mitochondria in H22 mouse ascites liver cancer cells, interfere with cancer cell division, block in the M phase, and affect its cycle speed. This product can destroy the skeleton of cancer cells (microfilaments, microtubules), affect the ultrastructure of cancer cells, and cause damage to mitochondria, microvilli and plasma membranes. It can inhibit DNA synthesis of cancer cells, but it does not inhibit normal bone marrow cells, and can increase white blood cells.

13114-29-9 0
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.